Bhiwandi: In an effort to provide quick solutions to revenue-related issues faced by citizens and farmers, the Bhiwandi Tehsildar Office has launched the “Chhatrapati Shivaji Samadhan Shivir Campaign ...

Direct multi-KRAS inhibitors, QTX3034 and QTX3544, exhibit potent activity against established and novel resistance mechanisms to ...

The purchase of a piece of land is one of the biggest financial decisions that most people make in their lifetime. However, the attractiveness of the price and the location of the land can sometimes ...

March 2026 arrives at a rare and drastic inflection point, as the global landscape undergoes a shift so volatile that the very state of world affairs feels caught in a permanent flux. And in this ...

RASolute 302 Phase 3 catalyst, cash runway, and valuation risks for daraxonrasib. Read more macro analysis here.

March 2026 arrives at a rare and drastic inflection point, as the global landscape undergoes a shift so volatile that the very state of world affairs feels caught in a permanent flux. And in this ...

Relay Therapeutics is approaching a pivotal clinical catalyst with the zovegalisib Phase 1/2 data readout at ESMO TAT. Check ...

The biliary tract cancer epidemiology section provides insights into the historical and current biliary tract cancer patient pool and forecasted trends for the leading markets. In 2024, the majority ...

Ocugen has completed enrollment in liMeliGhT, its phase 3 clinical trial of OCU400 for the treatment of retinitis pigmentosa (RP). The company describes liMeliGhT as a 1-year clinical trial that will ...

Abstract Methanol is an attractive one-carbon feedstock for sustainable biomanufacturing because of its abundance, cost-effectiveness, and industrial ...

FDA expanded zongertinib’s accelerated approval to treatment-naïve HER2-mutant advanced NSCLC, contingent on mutation ...

Total revenue of $68.7 million in 4Q25 and $172.4 million in FY2025 – – Revuforj® (revumenib) net revenue of $44.2 million in 4Q25, a 38% ...